Comparative genotoxicity of quinolone and quinolonyl-lactam antibacterials in the in vitro micronucleus assay in chinese hamster ovary cells

Environmental and Molecular Mutagenesis

Volumn 31, Issue 4, 1998, Pages 345-351

  Gibson, David P ^a   Ma, Xin ^a   Switzer, A Greg ^a   Murphy, Vincent A ^a   Aardema, Marilyn J ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

In vitro micronucleus assay; Quinolones; Quinolonyl lactams

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE INHIBITOR; GYRASE INHIBITOR; LACTAM; NALIDIXIC ACID; PENICILLIN BINDING PROTEIN; QUINOLONE;

ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; METAPHASE; MICRONUCLEUS TEST; NONHUMAN;

ANIMALS; ANTI-INFECTIVE AGENTS; CHO CELLS; CIPROFLOXACIN; CRICETINAE; DNA TOPOISOMERASES, TYPE II; MICRONUCLEUS TESTS; MUTAGENS; NALIDIXIC ACID;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031859159     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)31:4<345::AID-EM7>3.0.CO;2-H     Document Type: Article

References (21)

1. Albertini S, Kirsch-Volders M (1997): Summary and conclusions on the MNT in vitro and implication on testing strategies. Mutat Res 392:183-185.
2. Albertini S, Chetelat AA, Miller B, Muster W, Pujadas E, Strobel R, Gocke E (1995): Genotoxicity of 17-gyrase and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 10:343-351.
3. Ciaravino V, Suto MJ, Theiss JC (1993): High capacity in vitro micronucleus assay for the assessment of chromosome damage: Results with quinolone/naphthyridone antibacterials. Mutat Res 298:227-L.
4. Curry PT, Kropko ML, Garvin JR, Fiedler FD, Theiss JC (1996): In vitro induction of micronuclei and chromosome aberrations by quinolones: Possible mechanisms. Mutat Res 352:143-150.
5. Demuth TP, White RE, Tietjen RA, Storrin RJ, Skuster JR, Andersen JA (1991): Synthesis and antibacterial activity of new C-10 quinolonyl-cephem esters. J Antibiot (Tokyo) 44:200-209.
6. Domagala JM (1994): Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 33:685-706.
7. Ferguson LR, Baguley B (1994): Topoisomerase II enzymes and mutagenicity. Environ Mol Mutagen 24:245-261.
8. Ferguson LR, Whiteside G (1995): Detection of aneuploidy after treatment by amsacrine and other topoisomerase II poisons. In Abbondandolo A, Vig BK, Roi R (eds): "Proceedings on Chromosome Segregation and Aneuploidy." IST (Instituto Nazionale pe la Ricerca sul Cancro) Largo Rosanna Benzi, 10 Genova Edizione 1996.
9. Forte FL (1992): Mutagenicity of quinolone antibacterials. Drug Sa: 7:214-222.
10. Hamilton-Miller JMT (1994): Dual-action antibiotic hybrids. J Antimicrob Chemother 33:197-200.
11. Holden HE, Barett JF, Huntington CM, Muehibauer PA, Wahrenburg MG (1989): Genetic profile of nalidixic acid analog: A model for the mechanism of sister chromatid exchange induction. Environ Mol Mutagen 13:238-252.
12. Kirsch-Volders M (1997): Towards a validation on the micronucleus test. Mutat Res 392:1-4.
13. Marzin D (1997): The position of the in vitro micronucleus test within the battery of screening for genotoxic potential determination and regulatory guidelines. Mutat Res 392:175-181.
14. Matsuoka A, Yamazaki N, Suzuki T, Hayashi M, Sofuni T (1993): Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosome aberration test. Mutat Res 272:223-236.
15. McQueen CA, Way BM, Queener SM, Schluter G, Williams GM (1991): Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics. Toxicol Appl Pharmacol 111:255-262.
16. Miller B, Albertini S, Locher F, Thybaud V, Lorge E (1997): Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: Industrial experience. Mutat Res 392:45-49.
17. Miller B, Locher F, Seelbach A, Stopper H, Utesch D, Madle S (1998): Evaluation of the in vitro micronucleus test (MNT) as an alternative to the in vitro chromosomal aberration assay (CA): Position of the GUM working group on the in vitro micronucleus test. Mutat Res (in press).
18. Ralph RK, Judd W, Pommier Y, Kohn KW (1994): DNA topoisomerases, in: S. Neidle and M. Waring (Eds.), Topics in Molecular and Structural Biology: Molecular Aspects of Anticancer Drug-DNA Interactions. Vol. 2, 1st edn., MacMillan, London, pp. 1-95.
19. Shimada H, Itoh S, Hattori C, Tada S, Matsuura Y (1992): Mutagenicity of new quinolone anitibacterial agent Levofloxacin. Arzneim-Forsch./Drug Res (I), 3a:378-385.
20. Suto MJ, Domagala JM, Roland GE, Mailloux GB, Cohen MA (1992): Fluoroquinolones: Relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity. J Med Chem 25:25-30.
21. von Rosenstiel N, Adam D (1994): Quinolone antibacterials: An update of their pharmacology and therapeutic use. Drugs 47(6):872-901.